Citations for
1AVP, DIR3
Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin II gene.
de Fost M, van Trotsenburg AS, van Santen HM, Endert E, van den Elzen C, Kamsteeg EJ, Swaab DF, Fliers E.
Eur J Endocrinol 165(1):161-5. Epub 2011 Apr 15. 2011
2AVP, DIR3
A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus.
Tae HJ, Baek KH, Shim SM, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK.
Mol Genet Metab 86(1-2):307-13. Epub 2005 Jul 11. 2005
3AVP, DIR3
Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis.
Christensen JH, Siggaard C, Corydon TJ, deSanctis L, Kovacs L, Robertson GL, Gregersen N, Rittig S.
Eur J Hum Genet 12(1):44-51. 2004
4AVP, DIR3
Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor.
Rittig S, Siggaard C, Ozata M, Yetkin I, Gregersen N, Pedersen EB, Robertson GL.
J Clin Endocrinol Metab 87(7):3351-5. 2002
5AVP, DIR3
Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene.
Fujii H, Iida S, Moriwaki K.
Int J Mol Med 5(3):229-34. 2000
6AVP, DIR3
A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
Rutishauser J, et al.
Mol Genet Metab 67(1):89-92. 1999
7AVP, DIR3
Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.
Willcutts MD, et al.
Hum Mol Genet 8(7):1303-1307. 1999
8AVP, DIR3
Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins.
Ito M, et al.
J Biol Chem 274(13):9029-37. 1999
9AVP, DIR3
Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.
Siggaard C, et al.
J Clin Endocrinol Metab 84(8):2933-41 1999
10AVP, DIR3
Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant.
Grant FD, Ahmadi A, Hosley CM, Majzoub JA.
J Clin Endocrinol Metab 83 : 3958-3964. 1998
11AVP, DIR3
Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.
Repaske DR, et al.
J Clin Endocrinol Metab 82 : 51-56. 1997
12AVP, DIR3
Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II.
Gagliardi PC, Bernasconi S, Repaske DR.
J Clin Endocrinol Metab 82(11):3643-6. 1997
13AVP, DIR3
Idenditification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.
Rittig S, et al.
Am J Hum Genet 58 : 107-117. 1996
14AVP, DIR3
A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene : cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus.
Rutishauser J, et al.
J Clin Endocrinol Metab 81 : 192-198. 1996
15AVP, DIR3
A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene.
Ueta Y, et al.
J Clin Endocrinol Metab 81 : 1787-1790. 1996
16AVP, DIR3
Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus.
Repaske DR, et al.
J Clin Endocrinol Metab 81 : 2328-2334. 1996
17AVP, DIR3
Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus.
Nagasaki H, et al.
J Clin Endocrinol Metab 80 : 1352-1356. 1995
18AVP, DIR3
Recurring dominant-negative mutations in the AVP-NPII gene cause neurohypophyseal diabetes insipidus. (abstr)
Repaske DR, et al.
Am J Hum Genet 55 : A239. 1994
19AVP, DIR3
A De novo mutation in the coding sequence for neurophysin-II (Pro24-Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus.
Repaske DR, et al.
J Clin Endocrinol Metab 79 : 421-427. 1994
20AVP, DIR3
Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.
McLeod JF, et al.
J Clin Endocrinol Metab 77 : 599A-599G. 1993
21AVP, DIR3
Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.
Ito M, et al.
J Clin Invest 91 : 2565-2571. 1993
22AVP, DIR3
A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus.
Bahnsen U, et al.
EMBO J 11 : 19-23. 1992
23AVP, DIR3
A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.
Ito M, et al.
J Clin Invest 87 : 725-728. 1991
24AVP, DIR3
Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus.
Repaske DR, et al.
J Clin Endocrinol Metab 70 : 752-757. 1990